Kukjeon Pharmaceutical Co (XKRX:307750) Ending Cash Position : ₩11,307 Mil (As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Kukjeon Pharmaceutical Co Ending Cash Position?

Kukjeon Pharmaceutical Co's Ending Cash Position for the quarter that ended in Mar. 2025 was ₩11,307 Mil.

Kukjeon Pharmaceutical Co's quarterly Ending Cash Position increased from Sep. 2024 (₩4,715 Mil) to Dec. 2024 (₩46,824 Mil) but then declined from Dec. 2024 (₩46,824 Mil) to Mar. 2025 (₩11,307 Mil).

Kukjeon Pharmaceutical Co's annual Ending Cash Position declined from Dec. 2022 (₩21,546 Mil) to Dec. 2023 (₩10,992 Mil) but then increased from Dec. 2023 (₩10,992 Mil) to Dec. 2024 (₩46,824 Mil).

Kukjeon Pharmaceutical Co Ending Cash Position Historical Data

The historical data trend for Kukjeon Pharmaceutical Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kukjeon Pharmaceutical Co Ending Cash Position Chart

Kukjeon Pharmaceutical Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

9,779.38

19,099.16

21,545.99

10,992.40

46,823.70

Kukjeon Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Ending Cash Position	Get a 7-Day Free Trial															7,600.14	7,053.65	4,715.05	46,823.70	11,307.23

Kukjeon Pharmaceutical Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Kukjeon Pharmaceutical Co's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	10992.396	+	35831.3
	=	46,824

Kukjeon Pharmaceutical Co's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	46823.696	+	-35516.469
	=	11,307

Kukjeon Pharmaceutical Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Kukjeon Pharmaceutical Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Kukjeon Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kukjeon Pharmaceutical Co Ltd (XKRX:307750) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

282, Hagui-Ro, Dongan-Gu, Gyeonggi-Do, Number 1516, Geumgang Penterium IT Tower, Anyang-Si, KOR

Website

http://www.kukjeon.co.kr

Kukjeon Pharmaceutical Co Ltd supplies raw materials to domestic and foreign pharmaceutical companies and electronic material companies. Some of the products of the company include Artemisia Princeps Folium 95% ethanol soft extract, Bilberry Fruit Dry Extract, Dexibuprofen, Megestrol Acetate, and Benfotiamine.

Kukjeon Pharmaceutical Co Headlines

No Headlines